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ABSTRACT 
 
 
Traumatic brain injury (TBI) and subsequent rises in intracranial pressure (ICP) 
are associated with high mortality and has a number of physical and behavorial 
consequences to which the specific causes are unknown. We hypothesized that exposure 
of neuronal cells to elevated pressure can cause neurite retraction and / or apoptosis. Loss 
of communication between neurons due to these cellular-level events may play a part in 
complications seen in TBI patients, such as neurodegenerative diseases, increased 
anxiety, fear, depression, cognitive problems, as well as motor and visual deficits. In the 
present study, the effect of elevated hydrostatic pressure was evaluated at the cellular 
level in vitro by examining cell morphology, particularly neurite retraction and extension, 
as well as apoptosis. Neuro-2A cells (a mouse neuroblastoma cell line) were plated in cell 
culture dishes, as well as on soft polyacrylamide gel + type I collagen substrates. The 
cells were imaged using phase contrast microscopy (Nikon) before and after exposure to 
25 or 35 mmHg of hydrostatic pressure in a custom-made pressure chamber for 15, 30, 
60 min, as well as 4 and 6 hours. Pressure values were chosen to model elevated ICP 
correlated with moderate to severe TBI. Using the Fiji software, the post-pressure images 
were compared with the pre-pressure images of the same cells and the data were reported 
as normalized change in neurite length per cell. Additionally, TUNEL assay was 
performed using a commercially available kit (TiterTACSTM, Trevigen) to quantify 
apoptotic cells after exposure of Neuro-2A cells to 35 mmHg pressure. Results indicate 
that neurite length decreased significantly (p<0.05) when Neuro-2A cells were exposed to 
a pressure of 35 mmHg. When results are compared from 15, 30, 60 minutes and 4 hours 
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of pressure exposure, it appears that neurite retraction is correlated with exposure time. 
To further understand these morphological changes, the Rho/ROCK pathway was 
examined as a potential pathway involved in the mechanotransduction of hydrostatic 
pressure by neuronal cells. By using Y-27632 as a p160ROCK inhibitor, it was 
demonstrated that the pressure-induced neurite retraction response was blocked, therefore 
indicating the pathway’s involvement. The results of TUNEL assay indicated that the 
number of apoptotic cells were similar between the no pressure control and the cells 
exposed to 35 mmHg of pressure for 24 hours. The results of the present study provide 
evidence that elevated hydrostatic pressure causes Neuro-2A cell neurite retraction in a 
time-dependent manner in vitro. The model highlights the importance of urgent ICP 
clinical management, as elevated ICP caused by TBI may have a negative impact on 
neuronal tissue and contribute to further consequences.  
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1 
CHAPTER ONE 
 
INTRODUCTION AND BACKGROUND 
 
1.1 Introduction 
 
Traumatic brain injury is an immediate insult to the brain due to an external 
mechanical force that can range from mild to severe, resulting in both immediate and 
long-term effects (Caeyenberghs et al, 2014). Approximately 1.7 million traumatic brain 
injuries (TBI), 52,000 of which are fatal, occur every year in the United States, with an 
associated annual treatment cost of $70 billion (MedGadget, 2016). TBIs can result from 
a number of events including falls, vehicle accidents, assault, sports impacts, and 
battlefield blasts, and account for 50% of injuries sustained in war zone conflicts 
(MedGadget, 2016). The severity of TBI is classified as either mild, moderate, or severe. 
Concussions are a common type of mild TBI that occur largely due to sports impact 
injuries, and often go unreported or untreated due to their lack in severity. Moderate and 
severe TBIs are associated with higher mortality rates, and often result in severe 
disabilities (Caeyenberghs et al, 2014). Treatments exist to treat some secondary injury 
mechanisms, such as corticosteroids or calcium channel blockers (Xiong et al, 2009). 
However, no reliable treatment currently exists to alleviate the effects of TBI as a whole 
and prevent future consequences. 
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1.2 Anatomy and Physiology of the Brain  
1.2.1 Structures 
 The brain is the main organ of the nervous system and acts a control center that 
receives and processes information, then dictates responses. It is a complex structure with 
several tissue and cell types (McKinley et al, 2012). 
 The cerebral cortex, the outermost layer of the brain, is composed of gray matter, 
which contains motor neurons and interneuron cell bodies, dendrites, and unmyelinated 
axons (McKinley et al, 2012).   
 Cerebrospinal fluid (CSF) is an important component of the central nervous system 
(CNS) that circulates in the ventricles and subarachnoid space, and surrounds all exposed 
surfaces of the brain and spinal cord. The clear liquid not only protects and supports the 
brain, but also facilitates the transportation of nutrients, waste, and gases such as carbon 
dioxide and oxygen. The choroid plexus, a layer of ependymal cells and capillaries that is 
housed in each ventricle, produces CSF. After circulating in the ventricles, CSF enters the 
subarachnoid space where it removes waste products, and is then absorbed via arachnoid 
villi into the venous blood stream for eventual urinary excretion (McKinley et al, 2012). 
1.2.2 Cell Types 
 Brain tissue is composed of several cell types including neurons, astrocytes, 
microglial cells, oligodendrocytes, and ependymal cells (Pekna et al, 2012). Interneurons 
are the primary cell type of the central nervous system (CNS) and are responsible for 
signal transmission between sensory and motor neurons. These specific neurons are 
multipolar, meaning that they have multiple neurites- namely one axon and several 
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dendrites. Dendrites receive sensory information from stimuli and send it to the cell body 
for processing, from which an output signal is transported via the axon to the effector 
cell. This allows the interneurons to receive, store, and interpret sensory information, then 
dictate the response. Depending on the complexity of the response, several interneurons 
may be involved in the transmission process (McKinley et al, 2012). Thus, properly 
structured interneuron networks are essential to facilitate full functional signal processing 
and communication.  
 Astrocytes, microglial cells, oligodendrocytes and ependymal cells are classified as 
glial cells, which support the function of neurons and are able to undergo mitosis. 
Astrocytes are the most common type of glial cell. Their star-shaped structure allows 
them to provide structural support to neurons and organize nervous tissue, as well as 
contribute to forming the blood-brain barrier (BBB) through their connection with 
capillaries in the brain. Additionally, astrocytes regulate fluid composition in the brain by 
controlling molecular diffusion between blood and interstitial fluid. More importantly, 
astrocytes assist in neuronal development and synapse formation through the release of 
molecular signals. Ependymal cells are responsible for producing cerebral spinal fluid 
(CSF) in a structure called the choroid plexus. Microglial cells act as macrophages of the 
nervous system by migrating through the tissue and phagocytizing debris. 
Oligodendrocytes wrap around the axons of neurons to form the myelin sheath, which 
protects the axon while hastening signal transmission (McKinley et al, 2012).  
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1.2.3 Vasculature and Intracranial Pressure 
 Intracranial pressure (ICP) is determined by three components including tissue 
(brain and spinal cord), blood, and cerebrospinal fluid (CSF), which are housed in the 
skull and intervertebral canal, creating a fixed incompressible system. The Monroe-Kellie 
hypothesis states that the total intracranial volume remains constant. Therefore, when a 
volume increase in one of these components occurs, an equal decrease in another 
accommodates the change to maintain the appropriate intracranial pressure. For a normal 
healthy adult, the ICP ranges between 5 and 15 mmHg (Rangel-Castillo et al, 2008). 
 Another factor essential to maintain optimal ICP is the cerebral perfusion pressure 
(CPP). The CPP controls the cerebral blood flow (CBF) via the paired carotid and 
vertebral arteries, ensuring adequate blood flow and delivery of oxygen and glucose to 
brain tissue. More specifically, the blood vessels detect carbon dioxide concentration in 
the blood (partial pressure), and respond to increased partial pressure by vasodilation in 
order to increase CBF, and respond to decreased partial pressure by vasoconstriction, 
resulting in lowered CBF (Snyder, 2012). The CPP also depends on the mean arterial 
pressure (MAP), which is determined based on the individual’s systolic and diastolic 
blood pressure. In order to maintain adequate CPP, the ICP must be reduced, or the MAP 
increased (Rangel-Castillo et al, 2008).  
1.3 Traumatic Brain Injury 
1.3.1 Types of Traumatic Brain Injury 
 Depending on the type and location of the injury, certain structures within the brain 
are affected. Two main types of TBI occur including 1) focal trauma and 2) diffuse 
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axonal injury (DAI) (Gaetz, 2004). Focal trauma constitutes direct mechanical damage to 
brain tissue which affects local neurons and cerebrovasculature and leads to ischemia and 
cytotoxic cascades. It can also result in traumatically induced masses such as hematomas 
and hemorrhagic contusions. DAI accounts for about 40-50% of dysfunction associated 
with TBI. It affects superficial layers of brain tissue, particularly neurons and their axons, 
through acceleration and deceleration forces, then radiates deeper through the white 
matter (Gaetz, 2004). Specifically, DAI tends to affect certain brain regions including the 
parasagittal white matter of the cerebral cortex, the corpus callosum, and the pontine-
mesencephalic junction adjacent to the superior cerebellar peduncles (Ashley, 2010). 
1.3.2 Symptoms and Consequences of TBI 
 In moderate to severe TBI, there is a primary injury due to the initial impact which 
typically results in either a) contusions, lacerations, and intracranial hemorrhage, or b) 
diffuse axonal injury (Werner et al, 2007). Secondary injury results downstream of the 
primary insult as a consequence of cascading pathological biochemical processes such as 
disruption of cellular calcium homeostasis, increased free radical presence, lipid 
peroxidation, inflammation, apoptosis, and mitochondrial dysfunction (Xiong et al, 
2009). Several secondary events may occur, including elevated intracranial pressure 
(ICP) or intracranial hypertension, and cerebral ischemia (Werner et al, 2007).  
1.3.2.1 Short-Term Consequences 
 Upon impact, direct cell damage and death may occur immediately. Neuronal and 
glial cell death lead to disruption in neuronal circuitry due to synapse and neurite 
destruction between cells. Additionally, TBI disrupts blood flow and the blood-brain 
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barrier, CSF production and regulation, as well as cell metabolism and function (Pekna et 
al, 2012). Traumatic hemorrhagic contusions, as well as epidural hematomas or subdural 
hematomas may occur upon injury (Rangel-Castillo et al, 2008) and contribute to blood 
volume increase inside the skull (Alali et al, 2013). Cerebral edema, an increase in brain-
water content either intracellularly or extracellularly, may occur and increase fluid 
volume inside the skull (Alali et al, 2013). 
 Additionally, patients who suffer non-fatal severe TBI may experience coma or 
amnesia (Centers for Disease Control and Prevention, 2017). Other potential effects of 
severe TBI that may be either short or long-term include deficits in cognitive functions 
(attention and memory), motor functions (weakness, impaired balance and coordination), 
sensation (hearing, vision, touch), and emotion (depression, anxiety, aggression, 
impulsivity, personality changes) (Centers for Disease Control and Prevention, 2017). 
 In DAI, when the initial damage occurs, the local neurons experience cell 
membrane disruption, which leads to cytotoxic biochemical cascades and decline in cell 
health and function. More specifically, small ion species are believed to enter the 
disrupted axons, and inflict damage on the microtubules that compose the cytoskeleton 
(Gaetz, 2004). These local events eventually extend and affect distant structures as well 
(Ashley, 2010).  
 On the cellular level, DAI induces axolemmal permeability, allowing an influx of 
Ca2+ in the affected neurons at the primary injury site via calpain activation. This causes 
proteolytic digestion of a spectrin, which is a key component of the cytoskeleton 
membrane. These neurofilamentary changes may result in axonal cytoskeleton 
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mechanical failure. Negative downstream effects may occur such as mitochondrial 
migration from the cell body to the axon or axon terminals. Further axonal degeneration 
occurs over time. This specific degeneration may occur within days or months and 
progresses from initial axonal swelling to axonal bulb swelling, which then results in the 
aggregation of microglia. Within the first two years after DAI is sustained, the myelin 
sheath ultimately degenerates (Ashley, 2010). 
 On a macroscopic scale, DAI damages white matter and disrupts tissue organization 
in the brain. Previous studies that examined specific brain regions including the superior 
longitudinal fasciculus, corpus callosum, and cingulum fibre bundles demonstrated that 
TBI associated cognitive impairment correlates with white matter damage (Caeyenberghs 
et al, 2014). A study performed by Caeyenberghs et al, examined the effect of DAI on 
neural communication networks and found that TBI patients had disrupted topological 
organization of white matter networks which could have been responsible for observed 
decreased task-switching ability when compared with the control (Caeyenberghs et al, 
2014).   
1.3.2.2 Long-Term Consequences 
 Several long-term consequences are observed in TBI patients including those of an 
emotional, cognitive, and physical nature. Neuropsychological deficits associated with 
cognition include decreased mental flexibility, lack of planning and organizational skills, 
poor judgment, impaired attention, trouble with sequencing, speech impairment, 
increased impulsive behavior, and deficits with working memory. These effects are 
attributed mainly to diffuse axonal injury (DAI, Caeyenberghs et al, 2014). Impaired 
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memory has been observed in severe TBI patients, however there have been mixed 
reports in terms of mild and moderate TBI cases. Case study results find that sports 
impact injury patients sustained memory impairment, whereas veterans who experienced 
mild battlefield blast TBIs did not. Additionally, a decreased ability to recollect 
autobiographical details in TBI patients was correlated with increased CSF volumes in 
the bilateral genual cingulate gyrus, medial temporal lobe, anterior basal ganglia, left 
posterior cingulate gyrus, right anterior cingulate gyrus, and right posterior temporal, 
superior parietal, inferior parietal, and middle cingulate regions (Esopenko et al, 2017).    
1.3.2.2.1 Neurodegenerative Diseases 
 Previous studies indicate that moderate to severe TBI serve as a significant risk 
factor for the eventual development of neurodegenerative diseases such as Parkinson’s 
disease (Jafari et al, 2013), Alzheimer’s disease (Mortimer et al, 1991; Fleminger et al, 
2003) and amyotrophic lateral sclerosis (ALS, Chen et al, 2007), as well as 
frontotemporal dementia (Rosso et al, 2003; Kalkonde et al, 2012). While a holistic 
understanding of the all mechanisms responsible for linking the two pathologies remains 
unclear, several involved components have been elucidated.  
 Several correlations between traumatic brain injury and neurodegeneration 
associated with Parkinson’s disease (PD) exist. Animal studies have shown that after 
brain injury, protein accumulation and aggregation have occurred (Smith et al, 1999; 
Iwata et al, 2002), as well as proteosomal dysfunction (Yao et al, 2008), and an increase 
in nitrated α-synuclein (Uryu et al, 2003), as seen in PD patients. In post-mortem human 
studies, TBI patients exhibited increased levels of α-synuclein. α–synuclein aggregation 
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is a key indicator for the development of a neurodegenerative disease, as it is the main 
component present in Lewy bodies- abnormal protein aggregates observed in the neurons 
of PD dementia patients. It is hypothesized that α-synuclein aggregation may be due to 
disruption of axonal transport processes or axonal shear stress (Uryu et al, 2003; Siebert 
et al, 2010; Newell et al, 1999; Gaetz, 2004). Additionally, a study by Goldman et al 
found that patients with head injuries have overexpression of the alpha-synuclein 
(SNCA) gene and elevated levels of Rep1, which increases its transcription, suggesting 
that this is a contributor to the α -synuclein aggregation observed in PD (Goldman et al, 
2012). Moreover, α -synuclein aggregation activates microglia, which in turn activates α -
synuclein to aggregate when activated, creating a cycle of α –synuclein upregulation 
(Wilms et al, 2009; Zhang et al, 2005). 
1.3.2.2.2. Glial Scar Formation 
 Glial cells become activated as a protective response after neurotrauma in a process 
termed “reactive gliosis”. This process encompasses several events including the 
hypertrophy of astrocyte extensions, astrocyte proliferation, and elevated amounts of 
intermediate filaments. When activated, astrocytes immediately perform beneficial 
functions to protect surrounding tissue by preserving neuronal synapses, restricting the 
spread of injury, and aiding in wound repair. However, at a later stage of injury, glial scar 
activation has been shown to correlate with reduced regeneration of neuronal synapses 
and axons (Pekna et al, 2012).  
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1.3.2.2.3 Elevated Intracranial Pressure 
 Several factors compound to result in an increase in intracranial pressure (ICP) 
following TBI. As mentioned previously, hemorrhages and hematomas raise blood 
volume and edema increases fluid volume. Disruptions in CSF absorption can contribute 
to increased CSF volume throughout the CSF cavities, since the excess liquid cannot be 
removed and fresh CSF continues to be produced. Foreign bodies acquired during injury, 
or depressed skull fractures may also be introduced to the space (Rangel-Castillo et al, 
2008). With any or all of these increases in volume in the fixed space within the skull, 
intracranial pressure is forced to rise. Additionally, edema can compress cerebral 
vasculature, which reduces CBF, increases carbon dioxide concentration and 
consequently causes vasodilation and further increases ICP. When ICP increases enough, 
the brain loses the ability to autoregulate CBF (Snyder, 2012). ICP associated with mild 
to moderate TBI ranges from 20 to 30 mmHg, while an ICP of 40 mmHg or greater is 
correlated with severe TBI (Rangel-Castillo et al, 2008).  
 Rising ICP is often reflected in a patient’s mental status. Early on, the patient may 
exhibit confusion, later developing into a state of irritability, and ultimately transcending 
into combativeness. Severe headache and vomiting are indicative of subarachnoid 
hemorrhage and meningeal irritation as well as tissue compression. Unresponsiveness is a 
sign of the later stages of increased ICP. Additional late symptoms include seizures, a 
blown pupil, and Cushing reflex as a result of direct compression of the brain cortex 
tissue from hematomas or other expanding masses or free blood (Snyder, 2012). 
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 Increased ICP is known to be responsible for ischemia- when blood flow is 
restricted to brain tissue, resulting in cell damage and death, as well as cerebral 
herniation. Since the pressure increases in the fixed volume of the skull, sometimes the 
brain itself is pressed unnaturally against structures such as the tentorium cerebelli or the 
the cranial foramen, through which it herniates (Snyder, 2012). Other types of herniation 
that may occur due to elevated ICP include cingulate herniation, which occurs when the 
middle lobe of the brain shifts under the falx cerebelli, uncal herniation, which occurs 
when the uncus is pressed against the tentorium cerebelli and brain tissue is forced 
through the tentorial hiatus, cerebellotonsillar herniation, in which the cerebellum 
herniates through the foramen magnum and compresses the brain stem, and finally 
transcalvarial herniation, in which brain tissue is displaced to the exterior of the skull if a 
skull fracture exists (Snyder, 2012).  
1.3.2 Current Treatment for Controlling ICP 
 The initial stage of severe TBI treatment traditionally take place at the location 
where the injury occurred, followed by at the emergency department of the hospital to 
which the patient is transported, and ultimately the intensive care unit (ICU). The early 
acute care provided is crucial as it could prevent additional consequences and improve 
patient outcome. Critical steps include stabilization of the patient, prevention of ICP 
increase, and optimization of cerebral perfusion and oxygenation. To do so, medical 
personnel monitor the patient using electrocardiography, pulse oxymetry to measure 
arterial oxygen saturation, arterial blood pressure, electrolytes, osmolality, central venous 
pressure, and systemic temperature (Haddad et al, 2012).  
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 Since the primary brain injury cannot be repaired in TBI patients, physicians focus 
on treating the secondary injuries in hopes of eliminating or reducing further damage that 
may lead to long and short-term functional deficits or death. To date, no therapeutic has 
been successful in clinical trials to treat TBI secondary injury (Xiong et al, 2009). 
 Death and disability after severe TBI are most strongly correlated to high ICP, 
rather than any other TBI symptom (Xiong et al, 2009). Of those who die within the first 
48 hours following injury, the most likely cause is an uncontrolled rise in ICP (Alali et al, 
2013). Therefore, it seems vital that ICP is monitored closely when TBI patients receive 
treatment for their injuries (Xiong et al, 2009). However, some physicians argue the 
benefit from ICP monitoring due to its invasive nature, which could potentially further 
harm the patient. For example, results from a survey on practicing neurosurgeons in 
Canada, only 20% reported that they were highly confident in the benefit of invasive ICP 
monitoring in severe TBI patients (Alali et al, 2013). In a retrospective study performed 
by Alali et al, it was found that the use of invasive ICP monitoring was associated with 
lower in-hospital mortality rates for TBI patients, when compared to facilities that did not 
use invasive ICP monitoring for severe TBI patients (Alali et al, 2013).  
 ICP monitoring is an invasive technique that is associated with risks such as 
infection at the catheter placement site and hemorrhage or device malfunction. Therefore, 
it is only employed when patients exhibit signs of significant risk, which is usually 
evident on head CT scans. Detectable abnormalities include contusions, hematomas, 
herniation, edema and compression of basal cisterns (Rangel-Castillo et al, 2009).  
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 Current methods for ICP monitoring include the use of catheters in epidural, 
subdural, subarachnoid, parenchymal, and ventricular locations, with ventricular 
catheterization being the most common. Ventricular catheterization is often the most 
viable method as it is reliable, low-cost, and more accurate than other options. An added 
benefit is that this same catheter can be used for CSF drainage in the event that ICP needs 
to be lowered. ICP lowering techniques are employed when an ICP of 20 mmHg or above 
is detected (Haddad et al, 2012).  
 Elevated ICP is treated clinically based on the symptoms exhibited at the present 
time. Treatment is centered on protecting the airway, breathing, and circulation in an 
effort to maintain sufficient cerebral perfusion and avoid ischemic events. This is 
accomplished by administering oxygen, assuring adequate ventilation, and possibly 
hyperventilation in cases of herniation in order to decrease carbon dioxide concentration 
and induce vasoconstriction to lower ICP (Snyder, 2012).  
1.3.2.1 Medical Interventions 
 A common method to alleviate elevated ICP is the use of non-invasive 
hyperosmolar therapy (Rangel-Castillo et al, 2009). Osmotic diuretics such as mannitol 
and hypertonic saline (Rangel-Castillo et al, 2009) may be administered in order to draw 
excess fluid as a consequence of edema from the brain tissue and into intravascular space 
for elimination. This method, however, may not be ideal for all patients, such as those 
with previously existing conditions such as renal failure, hematomas or other blood-
related etiologies (Snyder, 2012). It is more successful in lowering ICP in patients who 
have an intact autoregulation system, as compared to those who do not. Specifically, with 
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a functional autoregulation system, mannitol can induce cerebral vasoconstriction which 
in turn maintains stable CBF and significantly lowers ICP. When the patient is unable to 
autoregulate pressure, mannitol only increases CBF, which leads to a small decrease in 
ICP (Rangel-Castillo et al, 2009). 
 Hypothermia (reducing body temperature to 32°C) is another treatment method 
used to control elevated ICP and improve patient overall outcome. There are several 
mechanisms through which this technique improves brain condition which include the 
following: improving cerebral blood flow, reducing metabolic rate, calcium antagonism, 
preventing excitotoxic cascades, preserving protein synthesis, modulating inflammatory 
response, protecting white matter, modulating apoptosis, and decreasing edema formation 
(Xiong et al, 2012). In a study performed by Markgraf et al, rats showed decreased 
cerebral edema and improved functional outcomes when hypothermia had been 
administered either immediately or 1 hour after TBI was sustained, as compared to those 
who had received the same treatment after 90 or 120 minutes where no benefit was 
observed (Markgraf et al, 2001). In a patient study, it was found that hypothermia 
sustained for at least 48 hours showed the best outcome, however this also puts the 
patient at risk of pneumonia. Hypothermia may also be beneficial to traumatic axonal 
injury, which is commonly observed in severe TBI (Xiong et al, 2012). 
 A last resort for severe TBI treatment is the administration of barbiturates to induce 
coma. This method should only be considered if the patient experiences refractory 
intracranial hypertension (RICH, when intracranial pressure exceeds 25 mmHg for 30 
minutes, 30 mmHg for 15 minutes, or 40 mmHg for 1 minute) because it is often 
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associated with serious complications such as hypotension and immunosuppression 
(Censullo et al, 2003; Haddad et al, 2012).  This treatment method may be selected in 
order to sedate the patient if their behavior becomes harmful to their condition, if it is 
beneficial to immediately reduce the metabolic needs of the brain tissue (Snyder, 2012), 
or to immediately lower ICP by lowering the metabolism, and in turn lowering CBF 
(Haddad et al, 2012).   
1.3.2.2 Surgical Interventions 
 The primary surgical procedure performed to alleviate elevated ICP is the removal 
of mass lesions such as acute epidural and subdural hematomas. Secondly, CSF drainage 
is employed by inserting a catheter into the ventricular space in order to immediately 
lower intracranial fluid volume and ICP (Rangel-Castillo et al, 2009).  
 Another last resort treatment for severe TBI and intracranial hypertension is 
decompressive craniectomy, in the event that medical management fails (Haddad et al, 
2012). Surgeons remove a portion of the skull in order to allow the swelling brain tissue 
to expand without being compressed against the rigid skull, and by opening the fixed 
volume of the skull, ICP is reduced (Xiong et al, 2009). The favorability of this technique 
is currently debated since conflicting evidence exists for its effect on patient outcome. 
Current clinical trials aim to clarify issues associated with the technique in regard to the 
timing of the operation, its role in secondary injury, and brain edema formation (Xiong et 
al, 2009). This method is used only as a last-ditch effort when the patient is close to death 
(Haddad et al, 2012). 
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1.4 Neuronal Cell Responses to Stress 
 Brain cells regularly experience stresses and respond to them accordingly. Several 
environmental stimuli such as drugs, cytokines, hydrostatic pressure, and other 
mechanical forces can evoke stress responses in cells. One response commonly examined 
in drug studies on neuronal cells is neurite retraction, since it is easily observable in this 
cell type.   
1.2.1 Neurite Retraction 
 Neurites are mainly composed of two cytoskeleton elements- microfilaments, and 
microtubules. Microtubules consist of tubulin and microtubule-associated proteins 
(MAPs), which when phosphorylated, appear to effect microtubule stability and 
dynamics. Neurite extension and retraction is controlled by reorganization of these 
components with the help of molecular motors, which are still not entirely understood 
(Sayas et al, 2006).  
1.2.1.1 Causes and Mechanisms 
 Neurite retraction has been studied in relation to several disease states. Neurite 
retraction plays a significant role in the progression of neurodegenerative diseases, as 
well as CNS injuries and glaucoma. Pathways have been identified as moderators of 
neurite retraction and extension, however their specific stimuli haven’t been identified. It 
is also unclear through which pathway hydrostatic pressure as a stimulus affects neuronal 
cells.  
 The Rho/ ROCK pathway has been identified as a moderator of actin cytoskeleton 
and consequentially neurite structure in previous studies (Hirose et al, 1988; Sun et al, 
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2011; Monnier et al, 2003). Specifically, activation of the small GTPase Rho and its 
downstream effector Rho kinase have been demonstrated to play a role in neurite 
retraction via the disassembly of intermediate filaments and microtubules (Hirose et al, 
1988). Additionally, a pyridine derivative Y-27632 has been characterized as a specific 
inhibitor of p160ROCK, a Rho-associated coiled coil-forming protein kinase within the 
Rho/ROCK pathway, which was shown to prevent neurite retraction in neuroblastoma 
N1E-115 cells (Hirose et al, 1988; Monnier et al, 2003). In a study by Hirose et al, N1E-
115 cells were serum-starved to induce neurite extension, then exposed to Y-27632. An 
agonist known to stimulate neurite retraction, lysophosphatidic acid (LPA), was added to 
the cell culture. Results indicated that p160ROCK was a downstream effector responsible 
for agonist-induced neurite retraction since the addition of Y-27632 prevented neurite 
retraction (Hirose et al, 1988). In a study by Sayas, glycogen synthase kinase-3 (GSK-3) 
was found to be activated by LPA in primary neurons based on GSK-3 activity 
measurement, while GSK-3 inhibition partially blocked neurite retraction. Additionally, 
results indicated that Neuro2A cells experience GSK-3 activation is mediated by the 
small GTPase RhoA (Sayas, 2006).  
1.2.1.2 Indications and Consequences 
 Neurites are an important component of the neuronal cell body as they establish 
synapses with other neurons, and thus create the interconnected neuronal network present 
in the brain. Neurite outgrowth during neurodevelopment is essential for neuronal 
connectivity, and a lack thereof can lead to cognitive deficits (Radio et al, 2008). While 
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several factors may have an influence on neurite retraction, the consequences involve loss 
of connection and communication in the neuronal network, and thus limited function.  
 Neurite outgrowth is commonly used to assess neuroInveity of certain chemicals. A 
reduction in length is interpreted as an interruption of proper development, and indicates 
some level of neurotoxicity with the assumption that the chemical of concern induces 
changes in molecular signaling pathways responsible for neurite extension (Radio et al, 
2008). 
 Neurite retraction is also associated with neurodegenerative diseases. 
Characteristics common to all neurodegenerative diseases include neurite retraction, 
synapse disruption and destruction, and eventual cell death (Sheinerman et al, 2013).  
 Additionally, LPA-induced neurite retraction has been associated with Tau 
phosphorylation, which is seen in the Alzheimer’s disease state. In a study by Sayas et al, 
it was determined that Tau phosphorylation was modulated by GSK-3 in the Rho 
pathway. It is possible that activation of GSK-3 involved in neurite retraction may also be 
linked to Alzheimer’s disease (Sayas et al, 1999). 
1.2.2 Neurite Retraction in TBI 
 Several indicators of neuronal injury exist, including blebbing, neurite retraction, 
and neurite thinning (Bar-Kochba et al, 2016). Neuronal injury and neurite retraction 
have been observed in experimental models of TBI that study the effects of mechanical 
insult from the primary injury. 
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1.2.2.1 In Vitro Findings 
 Neurite injury and retraction have been observed in studies using cell culture 
models of TBI. A study performed by Bar-Kochba et al utilized a 3D compression model, 
consisting of primary cortical neurons cultured in collagen type I gels, to characterize the 
effects of compressive impacts with specific strain rates on neuronal morphology. 
Samples were subjected to an compressive impact with different loading rates, at a 
compressive strain of 0.38 in quasistatic and dynamic loading. Through the use of 
confocal time-lapse microscopy, it was discovered that cytoskeleton showed signs of 
structural degeneration- including neurite retraction, thinning, and blebbing- six hours 
after experiencing the impact, then proceeding to deteriorate completely within four 
hours, eventually leading to cell death (Bar-Kochba et al, 2016).  
 Using micropatterned neuronal cell culture silicone membranes, Tang-Schomer et 
al modeled high strain rates responsible for white matter deformation in TBI. It was 
determined that dynamic stretching of neurons induced mechanical failure in axonal 
microtubules, which was responsible for disruption in axonal transport and swelling due 
to protein accumulation, leading to the complete axonal degeneration and eventual death 
of neurons (Tang-Schomer et al, 2010). 
 A study by Prado et al modeled TBI by using a novel device to apply stress to 
primary cortical neuronal cultures on a microelectrode array. Results indicated that 
membrane permeability was increased, along with spontaneous electrical activity 
perturbations, suggestive of electrophysiological dysfunction in the interconnected 
neuronal network (Prado et al, 2005).  
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1.2.2.2 In Vivo Findings 
 Previous in vivo studies have elucidated the effects that TBI has on neuronal and 
neurite morphology (Wu et al, 2012; Gao et al, 2011; DiLeanordi et al, 2009; Casella et 
al, 2014).   
 Several histological results following controlled cortical impact (CCI) injury to 
rodent models have illustrated the effects on tissue components. In a study by Wu et al, 
after CCI to the left hemisphere of Wistar rat subjects, it was discovered that along with 
neurological functional deficits, rats experienced axonal injury and decreased synaptic 
density following the injury (Wu et al, 2012). In a separate study, dentate gyrus tissue 
sections revealed that there was a significant decrease in dendritic length and dendritic 
branching following CCI injury to juvenile rat subjects when compared to the non-injured 
control (Casella et al, 2014). A mouse CCI injury model of mild TBI revealed that while 
there were no significant tissue lesions or cortex volume changes, there was evidence of 
some neuronal death and evidence of extensive dendritic degeneration marked by 
swelling and blebbing. Additionally, the number of apical dendrites and dendrite 
branches in pyramidal cells was greatly reduced in the mild TBI model, as well as the 
number of synapses between cells, and consequentially disruption of the neural circuitry. 
Since synapse degeneration was observed without the occurrence of neuronal death 
following the injury, it is possible that degeneration and death are separate processes that 
should be prevented individually (Gao et al, 2011).  
 A study that experimentally induced a diffuse injury TBI to a juvenile rat model 
demonstrated that axon swelling can occur in the cingulum 6 hours post-injury, followed 
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by additional axon swelling in the corpus callosum and lateral white matter tracts after 24 
hours. At 72 hours post-injury, results indicated axonal degeneration (DiLeonardi et al, 
2009).  
 Past studies have focused on the primary mechanical insult of TBI as the root cause 
for axonal injury, yet fail to evaluate how elevated ICP may contribute to pathologic 
mechanotransduction processes as well.  
1.3 Effects of Hydrostatic Pressure on Neuronal Cells 
 The application of hydrostatic pressure on different cell types and tissues is 
clinically relevant to a multitude of disease states. Hydrostatic pressure can mimic the 
functions of pressure states found in the body such as hypertension, elevated ICP, and 
intraocular pressure. By investigating the effect of hydrostatic pressure on a number of 
cell types and tissues, it may prove helpful in understanding the underlying mechanisms 
of cellular responses to TBI.  
1.3.1 Associated Pathologies 
There are several pathologies that result from or are exacerbated by super 
physiological levels of pressure. As previously discussed, TBI patients experience 
elevated ICP as a secondary condition, which has a direct effect on the physiology of the 
brain, and may lead to additional consequences such as neurodegenerative diseases.  
Another pathology that involves increased pressure is glaucoma. Glaucoma is 
associated with elevated intraocular pressure and the progressive degeneration of optic 
nerves, leading to loss of vision and eventually irreparable blindness. Retinal ganglion 
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cell death is a major factor involved in the pathophysiology of the disease, and may be 
wholly or in part due to increased intraocular pressure (IOP) (Almasieh et al, 2012).  
1.5.2 Effect on Cells  
Several in vitro studies have been performed to determine the effect of hydrostatic 
pressure on specific cell types to gain understanding of its physiological role in disease 
states. Cultured retinal ganglion cells (RGCs) are used in glaucoma model studies, as 
well as PC12 cells, which are also used in neurodegenerative disease studies.  
1.5.2.1 Retinal Ganglion Cells 
 RGCs are a type of Central Nervous System (CNS) neuron whose soma is located 
in the retina, and whose axons are located in the optic nerve (Almasieh et al, 2012). 
Studies have been performed on RGCs to determine if the elevated pressure contributes 
to neuronal apoptosis. In a study using differentiated RGC-5 cells housed in a pressurized 
live cell imaging chamber, it was discovered that after application of 100 mmHg pressure 
(a pressure that resembles the intraocular pressure observed in acute angle-closure 
glaucoma), the cells experienced peaks of intracellular Ca2+ elevation, followed by 
caspase-3/7 activation. Intracellular Ca2+ is a known apoptosis regulator, and caspase-3/7 
an apoptosis effector, so it was expected that the peaks of intracellular Ca2+ would 
correspond with morphological changes in the cells associated with apoptosis- cell 
shrinkage, and neurite retraction, which they did. This correlation of Ca2+ peaks with the 
morphological changes indicates that Ca2+ is the initiator of apoptosis in RGCs (Lee et al, 
2010).  
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 According to a 2013 study, results suggest that elevated IOP (90 mmHg for 1 hour) 
in a rat model resulted in the upregulation of the P2X7 receptor, and was responsible for 
RGC death. The P2X7 receptor is likely responsible for the upregulation of tumor 
necrosis factor (TNF)-α, interleukin (IL)-1β (a mediator in chronic inflammation and 
neurodegeneration), and IL-6 inflammation responses which contributed to cell death, as 
well as intracellular Ca2+ increase (Sugiyama et al, 2013). As observed in the previous 
study, elevated intracellular Ca2+ levels correlate to apoptosis. Other studies suggest 
transient receptor potential vanilloid-1 (TRPV1) expression may play a role in the 
increase of intracellular Ca2+ as well. TRPV1 is a channel that mediates multiple Ca2+ 
related cascades that influence the cell’s response to mechanical. In a glaucoma state 
mouse model, elevated IOP correlated with increased levels of TRPV1 and apoptosis 
(Sappington et al, 2015).    
 In addition to Ca2+  increase, apoptosis, and inflammatory response, new evidence 
suggests that elevated IOP induces oxidative stress in RGCs, which leads to neuronal 
damage. A study performed on both RGC-5 cells in culture and a mouse model 
concluded that after application of either 30 or 100 mmHg hydrostatic pressure, the 
oxidation products 4-hydroxy-2-nonenal (HNE) and heme oxygenase-1 (HO-1) were 
elevated in a dose-dependent manner. Results showed that HNE is toxic to RGC-5 cells, 
as it killed them in a dose-dependent manner. When pretreated with antioxidant 
resveratrol, HNE adduct formation was reduced in RGC-5 cells (Liu et all, 2007).  
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1.5.2.2 PC12 Cells 
 As an in vitro glaucoma model, PC12 cells (a rat adrenal phaeochromocytoma cell 
line, Westerink et al, 2008) subjected to elevated hydrostatic pressure experienced 
mitochondrial membrane depolarization that resulted in apoptosis and oxidative stress. 
PC12 cells in culture were exposed to 0, 15, and 70 mmHg hydrostatic pressure for 1 and 
24 hours. Afterwards, several factors were examined including cell viability, lipid 
peroxidation and intracellular reactive oxygen species production, mitochondrial 
membrane depolarization, reduced glutathione (GSH) and glutathione peroxidase (GSH-
Px), cell apoptosis, and caspase-3 and caspase-9 activities. When hydrostatic pressure 
was applied at either 15 or 70 mmHg, PC12 cells experienced oxidative cell damage as 
indicated by decreased GSH and GSH-Px values, as well as increased membrane 
potential of PC12 mitochondria, suggesting compromised mitochondrial activity. 
Application of 70 mmHg for 24 hours resulted in apoptosis as indicated by caspase-3 and 
caspase-9 values (Tök et al, 2014). 
 Another study indicate that neuronal exposure to increased pressure (as a model of 
high ICP in TBI patients) plays a role in the development of neurodegenerative disease. 
Neurodegenerative diseases such as Parkinson’s and Amyotrophic Lateral Sclerosis 
(ALS) develop as a result of protein aggregation comprised mainly of α-synuclein (AS). 
PC12 cells in suspension were subjected to either 500 or 1000 bars (375,030 mmHg to 
750,051 mmHg) of hydrostatic pressure for a certain period of time, and then allowed 24 
hours to recover. Western Blot results indicated that acute increases in hydrostatic 
pressure caused aggregation of intracellular endogenous AS, a decrease in its binding 
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partner PLCβ1, and reduced binding between in the two in PC12 cells. However, the 
exact mechanism through which this occurs remains unknown (Golebiewska et al, 2015). 
Although pressures used in this specific study were far greater than ICP observed in TBI 
patients, the results may be relevant. If PC12 cell behavior models central nervous system 
neuronal behavior as predicted, it is possible that increased ICP stemming from TBI 
contributes to the development of neurodegenerative diseases through the accumulation 
of AS,. 
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CHAPTER TWO 
RESEARCH RATIONALE 
2.1 Rationale 
 Approximately 1.7 million TBIs ranging from mild to severe occur every year in 
the United States (MedGadget, 2016). Resulting elevated ICP is managed with treatments 
such as hyperosmolar therapy, hypothermia, or craniectomy to reduce risk of ischemia 
(Rangel-Castillo et al, 2009; Xiong et al, 2012). However, it remains unclear what role 
elevated ICP has directly on cellular structure, and how it may play a role in pathological 
mechanotransduction pathways. Axonal degeneration, neurite retraction, and increased 
plasma membrane permeability are morphological characteristics that have been 
observed in several TBI models in vitro and in vivo studies. Since neurite retraction is a 
hallmark characteristic of neuronal cells in neurodegenerative diseases and functional 
nervous system deficits, it is possible that neurite retraction induced by TBI may manifest 
into the development of such pathologies. The present study investigates the direct role of 
elevated hydrostatic pressure on neuronal morphology alteration to elucidate processes 
that can be targeted for treatment options for TBI patients.   
2.2 Hypotheses 
 The objective of this present research is to test our hypothesis that neuronal cells 
respond to elevated hydrostatic pressure, and that this response is a facilitated via a 
specific pathway. To test this hypothesis, using custom experimental setups, mouse 
Neuro2A cells were subjected to controlled levels of hydrostatic pressure for specific 
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time periods, and cell morphology and apoptosis activity were examined. The specific 
aims for this project are as follows: 
• Aim 1: To quantify changes in Neuro2A cell morphology following exposure to 
elevated hydrostatic pressure  
Rationale: Axons and dendrites are vital to forming connections in the 
neural network that allow proper CNS function and cell-cell 
communication. Neurite retraction may lead to limited communication and 
therefore compromised functionality.  
Approach: Neuronal cell morphology was compared before and after 
exposure to hydrostatic pressure using fluorescent and phase contrast 
microscopic images. Normalized change in neurite length per cell was 
determined based on the comparison of  “before” and “after” neurite 
length summations. 
• Aim 2: To determine whether elevated hydrostatic pressure induces apoptosis in 
Neuro2A cells 
 Rationale: While direct injury to brain tissue during TBI can result in cell 
death, it is unclear whether unrelieved elevated intracranial pressure as a 
secondary injury associated with TBI contributes to cell death either 
locally or globally in the brain.  
 Approach: A colorimetric TUNEL Assay, TiterTACS, was used to 
determine whether Neuro2A cells underwent apoptosis after 1 hour or 24 
hours of exposure to 35mmHg hydrostatic pressure. 
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• Aim 3: To identify the mechanism through which hydrostatic pressure induces 
neurite retraction in Neuro2A cells  
Rationale: Once identified, the specific pathway could serve as a target for 
therapeutics that would act to reduce or prevent neurite retraction in 
neuronal cells induced by elevated intracranial pressure sustained after 
TBI, and limit subsequent consequences.  
Approach: Neuro2A cells were exposed to hydrostatic pressure in the 
presence or absence of Y-27632, an inhibitor to p160ROCK in the 
Rho/ROCK pathway. Neurite lengths for specific cells were measured and 
compared to determine the role of Rho/ROCK pathway in pressure-
induced neurite retraction. 
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CHAPTER THREE 
MATERIALS AND METHODS 
3.1 Pressure System 
 In the present study a custom-made pressure system was used to expose neuronal 
cell cultures to hydrostatic pressure. A computer with a custom LabView code (National 
Instruments, Corporation, Austin, Texas) was used to regulate the pressure inside a sealed 
pressure chamber, which housed the cell culture dishes. A pressure transducer was used 
to monitor the pressure inside the pressure chamber and convey the pressure to LabView 
using voltage output values. Based on the readings, inlet and outlet valves that controlled 
the flow of 95% air/ 5% CO2 through the pressure system were adjusted. The pressure 
chamber was housed inside an incubator under standard cell culture conditions.  
 In addition to the previous design of a rectangular chamber (Figure 1), a new 
pressure chamber (Figure 2) was designed and fabricated in the present study to 1) limit 
space inside the container for air to fill and therefore reducing pressure pump usage, 2) 
provide a cylindrical shape to house petri dishes or cell culture dishes, 3) to achieve 
capacity for higher pressures. 
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Figure 1. Pressure Chamber 1. Rectangular pressure chamber with box lid 
mechanism used for low-pressure experiments.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Pressure Chamber 2. Newly fabricated cylindrical pressure chamber 
with screw-top lid for high-pressure experiments. 
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3.2 Cell Culture 
 Neuro2A cells (ATCC), a mouse neuroblastoma cell line, were cultured in 
Dulbecco’s Modified Eagle Medium (D-MEM) supplemented with 10% fetal bovine 
serum (FBS) and 1% Penicillin-Streptomycin (Thermo Fisher Scientific) under standard 
cell culture conditions with a humidified atmosphere of 95% air and 5% CO2 at 37°C. 
Media were changed out every 48-72 hours. Cells were passaged when 80% confluency 
was achieved, approximately once a week using a trypsin-EDTA solution (Corning). 
  In order to induce neurite extension, cells were serum-starved for 24 hours 
(Figure 4). This was accomplished by replacing regular growth media (D-MEM, 10% 
FBS, 1% Penicillin-Streptomycin) with serum-free media (100% D-MEM).  
3.3 Soft Substrate Coating 
To simulate an environment that mimicked that of brain tissue, a polyacrylamide 
+ type I collagen layered substrate was prepared for Neuro2A cell culture. The protocol 
in the present study was adapted from that developed by Fischer et al (Fischer et al, 
2012). 
3.3.1 Coverslip Acid Washing 
 One-inch circular glass coverslips (Fisher Scientific) were soaked in a beaker 
containing 20ml 1M HCl in a hot water bath at 50-60°C under a fume hood for 8 hours 
with occasional agitation. The coverslips were removed and rinsed extensively in distilled 
water and subsequently in 100% ethanol. Coverslips were left to air-dry overnight.  
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3.3.2 Coverslip Activation 
 The acid-washed coverslips were carefully placed in a wire rack and soaked in 
0.5% (3-aminopropyl)trimethoxysilane (Sigma-Aldrich) in dH2O for 30 minutes at room 
temperature with gentle agitation of the rack in solution. After washing in six changes of 
dH2O the rack carrying the coverslips was dried on a hot plate and cooled to room 
temperature. After cooling the coverslips on the rack were immersed in a 0.5% 
glutaraldehyde (Polysciences)-PBS solution for 30 minutes at room temperature with 
occasional agitation to prevent bubble accumulation on the coverslip surface. The 
coverslips were then washed with three changes of distilled H2O and allowed to air-dry 
overnight.  
3.3.3 Polyacrylamide Gel Coating 
 Glass slides (Fisher Scientific) were polished with a KimWipe soaked in a 
hydrophobic silicone solution (Rain-X, ITW Global Brands), rinsed well with distilled 
water, and then allowed to air dry. Two glass slides were placed in each 15cm glass Petri 
dishes. To prepare acrylamide gel with a shear modulus of 0.43 kPa to mimic that of 
brain tissue (~0.49 kPa, Rashid et al, 2013), 0.2925 mL acrylamide, 0.1604 mL bis-
acrylamide, 2.0471 mL1M HEPES were mixed together for a total volume of 2.5 mL 
with the final concentrations of 5% acrylamide and 0.05% bis-acrylamide. To this 
mixture, 10 µL of TEMED and 15 µL of freshly made 10 % APS were added and mixed 
briefly. Two 12 µL drops of the whole mixture were placed with 1 inch space apart on 
each glass slide and one coverslip was carefully placed on each drop, with a small portion 
of the coverslip overhanging the edge of the glass slide. The acrylamide mixture was 
 33 
allowed to polymerize at room temperature for 20 minutes. After polymerization was 
completed, the surface of the slides and coverslips were flooded with freshly made 50 
mM HEPES buffer. The coverslips were then removed from the glass slides using forceps 
by applying lateral pressure to the overhanging edges of the coverslips. The coverslips 
were placed gel side-up in another Petri dish and rinsed five times with 50 mM HEPES 
buffer. The polyacrylamide-coated coverslips were stored in fresh 50 mM HEPES buffer 
at 4°C overnight prior to the collagen coating step.  
3.3.4 Type I Collagen Coating of Soft Substrates  
 Sulfo-SANPAH (Thermo Fisher Scientific) stock in dimethyl sulfoxide (DMSO, 
ATCC) at a concentration of 25 mg/mL was prepared and flash-frozen in liquid nitrogen 
for storage at -80°C. Four 40 µL aliquots of sulfo-SANPAH were thawed at room 
temperature and 960 µL of distilled water was mixed with each aliquot. The type I 
collagen solution was prepared at a concentration of 200 ug/mL in PBS. The cover slips 
were placed gel side-up on a Parafilm coated Petri dish. 200 µL sulfo-SANPAH solution 
was pipetted onto the polyacrylamide surface of each coverslip. The Petri dish supporting 
the coverslips was placed on top of a heightened support in the cell culture hood so that it 
was ~10 cm from the UV lamp and left for 10 minutes to induce cross-linking. After 
excess buffer was removed from coverslips, each coverslip was inverted onto a single 
collagen droplet so that the polyacrylamide surface was in contact with the droplet. The 
collagen was allowed to covalently couple with the polyacrylamide overnight at 4°C. The 
following day, the coverslips were rinsed with sterile PBS in sterile conditions and a grid 
was drawn on the bottom of each coverslip with a permanent marker. Coverslips were 
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stored in fresh sterile PBS in cell culture dishes. Coverslips were sterilized by UV light 
for 3 hours at room temperature. Coverslips remained in their cell culture dishes and were 
stored at 4°C.  
3.3.5 Coomassie Blue Staining 
  To confirm the immobilization of collagen onto the soft substrates, the coverslips 
were fixed in fixing solution (50% methanol, 10% glacial acetic acid in dH2O) for 3 
hours and stained with Coomassie blue (40% methanol, 60% Coomassie Blue + acetic 
acid in dH2O) for 20 minutes with gentle agitation. The samples were then destained 
eight times in destaining solution (40% methanol, 10% glacial acetic acid in dH2O) and 
stored for imaging in storage solution (5% glacial acetic acid in dH2O) Macroscopic 
images were taken of each coverslip using a cell phone camera and microscopic images 
were taken using phase contrast microscopy (10x, Nikon). 
3.3.6 Cell Seeding onto Gel Coverslips 
 Each coverslip was rinsed in warm sterile PBS, then placed gel side up in a 35 mm 
cell culture dish with 1 mL warm growth media. N2A cells (56,600 cells per dish) in 
growth media were seeded on each coverslip and cultured for 24 hours. 
3.4 Pressure Experiments  
 Prior to cell seeding, a grid coordinate system was drawn on the bottom of each cell 
culture dish using a permanent marker (see Figure 3), which allowed for the relocation of 
individual cells. Neuro2A cells were cultured in 35mm cell culture dishes at an initial 
seeding density of 56,600 cells per dish in growth media for 24 hours. Growth media was 
removed and cells were cultured in serum-free media (100% D-MEM) for 24 hours in 
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order to induce neurite extension. At this point, “Before” images were taken of Neuro2A 
cells using the microscope (Nikon). The specific cell locations were recorded in order to 
locate the same cells for the “After” images. Using the custom setup (Section 3.1), the 
cells were exposed to hydrostatic pressure (either 25 or 35 mmHg) for 30 min, 1hour, 2 
hours, or 4 hours. Control was the cells that were prepared in a similar manner but 
maintained under atmospheric pressure conditions for the duration of the experiments. 
Immediately following the pressure application, cells in all dishes were fixed with 10% 
neutral buffered formalin (NBF, Protocol) for 10 minutes.. “After” images of the same 
cells captured in the “Before” images were taken using phase contrast microscopy 
(Nikon). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Cell Culture Dish Grid Schematic. A coordinate grid that was 
drawn on the bottom of each cell culture dish using a permanent marker was 
used to locate cells. 
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3.5 Microscopy 
 Cells were imaged using phase contrast and fluorescence microscopy (Nikon). 
CellLight Actin-GFP, BacMam 2.0 (Thermo Fisher Scientific) was used to label actin in 
the Neuro-2A cells with green fluorescent protein for live cell fluorescence imaging.  
3.6 Neurite length analysis 
3.6.1 Image analysis  
 Neurite length was measured for individual Neuro2A cells using the Fiji program 
with the Simple Neurite Tracer plugin (Longair, 2011). The program allows for manual 
selection of end points for measurement, and reports the length in units of pixels. The 
number of neurites per cell, as well as the length of each neurite per cell were measured 
on the “Before” images and the “After” images for all groups.  
3.6.2 Calculations 
 Normalized change in neurite length was calculated using the following equation: 
 
 
 
 
 
  
 
Equation 1. Equation used to determine average normalized change in 
length per neurite per cell 
 37 
 
The variables are defined below: 
 
 
 
Hence, ΔL=1 signifies no change in neurite length per cell, while a value above 1 
indicates increase in neurite length, and a value below 1 represents a decrease in neurite 
length.  
3.7 p160 ROCK Inhibition 
3.7.1 Part One: Pressure and Y-27632 
To determine the potential mechanism for pressure-induced neurite retraction in 
N2A cells, the pressure experiments (35 mmHg, 1 hour) were repeated with or without 30 
min pre-treatment of cells with a ROCK inhibitor Y-27632 (1 µM, ATCC). Four 
experimental groups were designated as 1- No Pressure, 2- No Pressure + Y-27632, 3- 
Pressure, and 4- Pressure + Y-27632.  
3.7.2 Part Two: LPA and Y-28632 
 In addition, to confirm the involvement of Rho-Rock pathway in neurite retraction 
and effect of the inhibitor, a positive control experiment was performed. 
Lysophosphatidic acid (LPA) is a bioactive phospholipid known to cause neurite 
retraction in neuronal cells. By using it as a neurite retraction stimulus in place of 
hydrostatic pressure, LPA was applied to cells in order to provide a comparison for the 
reaction observed in cells exposed to pressure. Briefly, following serum-starvation for 24 
ΔL =  normalized change in neurite length per cell 
l0  = combined length of neurites for a cell BEFORE  
N0 = number of neurites for a cell BEFORE 
l = combined length of neurites for a cell AFTER 
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hours, Neuro2A cells were treated with 1 µL Y-27632 solution each for 30 minutes and 
imaged using phase contrast microscopy (Nikon). The cells were then treated with a 
lysophosphatidic acid (LPA) solution [0.3mM LPA, Sigma-Aldrich, in PBS, Corning, 
0.1% weight/ volume bovine serum albumin (BSA), Sigma-Alrich] for 10 minutes. Cells 
in all dishes were fixed with 10% neutral buffered formalin (NBF, Protocol) for 7 
minutes and imaged again.  
3.8 TUNEL Assay  
 After pressure experiments (35 mmHg, for 1 hour or 24 hours), TUNEL assay 
was performed using a commercially available kit (TiterTACSTM, Trevigen) and 
following the manufacturer's instructions (Batch Method) to quantify apoptotic cells. 
Duplicates for each group (4 groups total) were assayed. The 4 groups included the 
following: Control group (no pressure), Pressure group, Positive control (nuclease-
treated), and Negative control (unlabeled). The Control group, Positive control, and 
Negative control groups all used cells that were not exposed to pressure.  
3.9 Polyacrylamide / Collagen Type I Coating of Substrates 
 Soft culture substrates for N2A cells were prepared according to a published 
method (REF), which is summarized in the following subsections. 
 
3.10 Statistical Analysis 
 A paired t test (two tail) was performed when appropriate. The level of 
significance used was p < 0.05. All data are presented as means ± standard errors of 
mean.  
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CHAPTER FOUR 
RESULTS 
4.1 Neuro2A Cell Neurite Extension 
 Neuro2A cells were cultured in growth medium containing D-MEM, 10% FBS, 
1% Penicillin-Streptomycin for 24 hours. Medium was switched to serum-free media 
(100% D-MEM) for 24 hours in order to induce neurite extension from the cell body. 
Phase contrast images exhibited that there were more neurites per cell, and that those that 
existed were longer in length in the serum-free media group (Figure 4A) than the regular 
media group (Figure 4B).  
 
 
Figure 4. Phase Contrast Images of Neuro2A Cells in Growth Medium and Serum-
Free Medium. Neuro2A cells cultured in regular growth media containing D-MEM, 
10% FBS, 1% Penicillin-Streptomycin after 24 hours (A) and Neuro2A cells cultured in 
serum-free growth media containing 100% D-MEM after 24 hours.  Scale bars = 100 µm.  
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4.2 Neurite Response to Pressure Exposure 
4.2.1 Hard Substrate   
 To determine elevated hydrostatic pressure on neuronal cell morphology in vitro, 
Neuro2A cells cultured in 35 mm plastic dishes (Greiner Bio-One) were exposure to 
pressure (25 or 35 mmHg for up to 60 min) and imaged using phase contrast microscopy 
(Nikon) (Figure5).  
Figure 5. Phase Contrast Images of Neuro2A Cells Before and After Pressure 
Application. Neuro2A cells cultured in serum-free media and imaged (A, D) at 
time=0, (B) after 15 minutes in incubator (no pressure), (C) after 30 minutes in 
incubator (no pressure), (E) after 15 minutes of exposure to 35 mmHg pressure, (F) 
after 30 minutes of exposure to 35 mmHg pressure.  Scale bars = 100 µm.  
 
Neurite length of about 30 cells from each dish was measured and 
normalized length was calculated for both the pressure group and a control group (no 
pressure). The cells exposed to these two different pressures show similar general trend 
and exhibited a decrease in neurite length when compared with the control. However, 
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only application of 35 mmHg induced a significant (p<0.05) decrease in neurite length. 
Based on these results, 35 mmHg pressure was used in subsequent experiments to 
evaluate the effect of pressure on neurite length at additional time points. 
Figure 6. Average Normalized Change in Neurite Length Over 1 Hour. Average 
neurite length per cell was normalized over two 30-minute segments for control group 
(no pressure) and pressure (either 25 mmHg or 35 mmHg) groups of Neuro2A cells. 
Error bars indicate ± S.E.M. * indicates p < 0.05.  
Overall, the results demonstrated that pressure group experiences a decrease in 
neurite length when compared to the control group. Specifically, neurite length of the 
Neuro2a cells decreased significantly (p<0.05) after 30 minutes, 60 minutes, and 4 hours 
of exposure to 35 mmHg hydrostatic pressure. Additionally, it appears that change in 
neurite length is time dependent up to at least 4 hours.  
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Figure 7. Average Normalized Change in Neurite Length Over Time at 35 mmHg 
Pressure. Average neurite length per cell was normalized over time segments for control 
group (no pressure) and pressure (35 mmHg) group of Neuro2A cells. Error bars indicate 
± S.E.M. * indicates p < 0.05.  
4.2.2 Soft Substrate 
To examine neuronal cell morphology changes due to hydrostatic pressure in an 
environment similar to that of brain tissue, a soft substrate was prepared based on the 
published methods (Fischer et al, 2012). Cells seeded on the soft polyacrylamide gel + 
type I collagen substrate were imaged using phase contrast microscopy (Nikon) before 
and after exposure to either 35 mmHg pressure or no pressure (control) for 1 hour. Data 
were compared to that acquired from the hard substrate experiment.  
First, to confirm that the collagen was immobilized onto the polyacrylamide gel 
layer on the coverslip, a Coomassie Blue stain was performed (de Moreno et al, 1986; 
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Duhamel, 1983). Resulting images show that both coverslips A and B have clear and 
blue-colored regions, with coverslip B having slightly more blue spots (Figure8). 
Figure 8. Coomassie Blue Staining of Polyacrylamide Gel Coverslips. After 
Coomassie Blue stain was performed, images were taken on a phone camera of the 
coverslips which had either A) a polyacrylamide gel layer or B) a polyacrylamide gel 
layer + type I collagen layer.  
Unlike Neuro2A cells on the hard substrate, most Neuro2A cells on the soft 
substrate appear to have a more rounded cell body and to have fewer neurite extensions 
(Figure 9). Neuro2A cells seeded on the soft substrate appear to experience neurite 
retraction similar to that of Neuro2A cells plated on the hard substrate when exposed to 
35 mmHg hydrostatic pressure for 1 hour (Figure 10). Neurite length decreased 
significantly on both the hard substrate and the soft substrate (p < 0.05). 
A B 
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Figure 9. Phase Contrast Images of Neuro2A Cells Seeded on Soft Substrate. 
Phase contrast images were taken of Neuro2A cells (A, C) at time=0, (B) after 1 
hour (no pressure), and (D) after 1 hour of exposure to 35 mmHg hydrostatic 
pressure. Scale bars = 100 µm.  
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Figure 10. Average Normalized Change in Neurite Length Over 1 Hour on Hard 
and Soft Substrates. Average neurite length per cell was normalized over 1 hour for 
control group (no pressure) and pressure (35 mmHg) group of Neuro2A cells. Error 
bars indicate ± S.E.M. * indicates p < 0.05.  
4.3 p160 ROCK Inhibition 
To determine whether hydrostatic pressure induced neurite retraction through the 
Rho/ROCK pathway, experiments were repeated in the presence or absence of the p160 
ROCK inhibitor Y-27632 with LPA-treated group of Neuro2A cells as a positive 
control. Imaging of the cells and calculation of the normalized neurite 
lengths demonstrated that the control groups and the Y-27632 groups experienced slight 
* * 
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changes, while the others experienced a significant (p<0.05) decrease in length (Figure 
11). There was a significant difference between the Y-27632-treated cells and non-treated 
cells in both the pressure and LPA groups.
Figure 11. Average Normalized Change in Neurite Length Over 1 Hour for 
Treatment Groups With or Without Exposure to Inhibitor Y-27632. Average 
change in neurite length per cell was normalized over 1 hour for control group (no 
pressure), control group (no pressure) + Y-27632, pressure (35 mmHg) group, 
pressure (35 mmHg) group + Y-27632, LPA group, and LPA + Y-27632 group of 
Neuro2A cells. Error bars indicate ± S.E.M. * indicates p < 0.05.  
*
* 
47 
4.4 Apoptosis Study 
To determine the effect of elevated hydrostatic pressure on Neuro2A cell apoptosis, a 
commercially available colorimetric TUNEL assay kit (Trevigen), was used to quantify 
the level of apoptotic Neuro2A cells directly after 24 hours of exposure to pressure (35 
mmHg). Positive (nuclease-treated group) and negative (unlabeled group) controls were 
generated to interpret absorbance values, with high values (0.611-1.159) indicating 100% 
apoptotic cells, and low values (~0.111-0.211) indicating minimal apoptotic cells present 
(Figure 12). The average values indicate that minimal apoptosis is detected in both the 
control and pressure groups with absorbance values of 0.3055 and 0.3500, respectively, 
which fall between the positive and negative control absorbance values. 
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Figure 12. Quantification of Apoptosis in Neuro2A Cells Using HT TiterTACS 
Assay. TiterTACs Assay was performed to quantify apoptosis in Neuro2A cell 
cultures directly after 24 hours of exposure to 35 mmHg hydrostatic pressure. Error 
bars indicate ± S.E.M.  
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CHAPTER FIVE 
DISCUSSION 
Although numerous studies have previously investigated pathological 
mechanisms involved in TBI (Bar-Kochba et al, 2016; Casella et al, 2014; DiLeonardi et 
al, 2009; Gao et al, 2011; Prado et al, 2005; Tang-Schomer et al, 2010; Wu et al, 
2012; Xiong et al, 2009), none have studied the direct effect of elevated ICP on neuronal 
cell mechanobiology. As there is currently no therapeutic treatment available for 
secondary injury after TBI (which may be partly due to elevated ICP), researchers aim to 
elucidate potential pathways to target for therapeutic approaches (Xiong et al, 2009). 
Additionally, an understanding of the mechanisms involved in elevated ICP may provide 
insight necessary to establish conventional elevated ICP management procedures in TBI 
patients, which currently remains debated amongst physicians (Alali et al, 2013). 
Previous studies have examined changes in neuronal cell morphology and health in vitro, 
particularly neurite extension/retraction and apoptosis, in order to evaluate cell health in 
response to drugs and other chemicals (Hirose et al, 1988; Monnier et al, 2003; Sayas, 
2006). In the present study, changes in neurite length was measured to determine the 
effect of elevated hydrostatic pressure on Neuro2A cells as an in vitro model of TBI-
associated elevated ICP. It was hypothesized that elevated hydrostatic pressure would 
induce neurite retraction, and possibly apoptosis, in the Neuro2A cell culture model.   
5.1 Neuro2A Cell Differentiation 
Neuroblastoma cells are frequently used in in vitro studies to investigate neuronal 
cell behavior (Seeds et al, 1970; Schubert et al, 1974). A number of methods exist for 
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differentiating neuroblastoma cell lines and inducing neurite outgrowth, with the simplest 
being exposure to serum-free medium (Gurwitz et al, 1988; Schubert et al, 1971; 
Schubert et al, 1974; Seeds et al, 1970). When serum is removed from the environment, 
the protein synthesis that is required for the microtubule assembly involved in 
neurite extension, occurs (Seeds et al, 1970). Additionally, it is possible that after serum 
removal, the cells are able to interact with the plate surface more stably, and thus 
form neurites on its surface (Seeds et al, 1970; Schubert et al, 1971). In the present study, 
Neuro2A cells were first cultured in growth medium (D-MEM, 10% FBS, 1% Penicillin-
Streptomycin), then switched to serum-free medium (100% D-MEM) after 24 hours, 
which led to successful differentiation indicated by neurite outgrowth. In the present 
study, differentiation was necessary in order to achieve a neuronal phenotype as clinically 
relevant as possible. 
5.2 Neurite Response to Pressure Exposure 
The present study examined the effects of elevated hydrostatic pressure on 
Neuro2A cell morphology, particularly neurite retraction/extension. The majority of 
the experiments were performed in polystyrene cell culture dishes (Greiner Bio-
one) while some experiments were performed with a soft substrate layer (Greiner Bio-
one, plus polyacrylamide + type I collagen gel) to mimic brain tissue stiffness. 
5.2.1 Hard Substrate   
Differentiated Neuro2A cells were exposed to pressure (25 mmHg or 35 mmHg) for 
either 15 minutes, 30 minutes, 60 minutes, 4 hours, or 6 hours. The pressures of 25 
mmHg and 35 mmHg were selected to mimic those of ICP observed in moderate and 
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severe TBI patients, respectively (Rangel-Castillo et al, 2008). Phase contrast 
images analyzed with the Fiji program with the Simple Neurite Tracer plugin (Longair, 
2011) showed that there was neurite retraction and extension in both the control and 
pressure groups. This is most likely due to the fact that the cells naturally migrate, as well 
as react to differences in temperature when being removed from the incubator and being 
transported to the microscope. Thus, the study aimed to compare the amounts of change 
in neurite length between the control and pressure groups in order to determine whether 
there was a difference.  
The results comparing the 25 mmHg and 35 mmHg pressure groups provided 
evidence that cells in the 35 mmHg group experienced a more drastic decrease in neurite 
length than those in the 25 mmHg group when exposed to pressure for 30 and 60 minutes 
(Figure 6). The trend indicated that neurite retraction may occur at moderate pressures 
(~25 mmHg), and progress extensively as pressure continues to rise (to at least 35 
mmHg).  
Since Neuro2A cell exposure to 35 mmHg pressure results indicated that there was 
significant impact, subsequent studies were performed in order to more closely examine 
the effect of 35 mmHg pressure on neuronal cell morphology at additional time 
points.  The results provide evidence that exposure to 35 mmHg pressure for 30 minutes 
or more causes significant (p<0.05) neurite retraction in Neuro2A cells in cell culture 
dishes. After 6 hours of exposure to 35 mmHg pressure, neurite length did not decrease 
as much as it did after 4 hours. While it is possible that neurites began extending after the 
4 hour time point, the observation in the 6 hour group is most likely due to the fact that 
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there was greater variability in the data due to more extensive cell migration after such a 
long period of time.  
Together, the results indicate that neuronal cells present in brain tissue exposed to 
elevated ICP in severe TBI patients may experience neurite retraction. Neurite retraction 
induced by ICP may lead to disruption in the brain's neuronal network by destroying 
synapses and cell-to-cell communication (Gao et al, 2011). It is possible that neurite 
retraction as a result of elevated hydrostatic pressure may play a role in the development 
of long-term consequences commonly observed in TBI patients such as 
neurodegenerative diseases (Chen et al, 2007; Fleminger et al, 2003; Jafari et al, 2013; 
Mortimer et al, 1991) and cognitive deficits (Caeyenburghs et al, 2014) since these are 
also characterized by neurite retraction (Radio et al, 2008; Sheinerman et al, 
2013). Additionally, the presented evidence supports the notion that elevated ICP (~35 
mmHg) in severe TBI patients should be relieved as soon as possible, ideally within 30 
minutes of elevated ICP detection, in order to avoid neuronal cell damage. Neurite 
retraction is one form of neuronal cell damage that was observed, however, 
additional cellular pathologic events may occur that were not observed in the present 
study.  
5.2.2 Soft Substrate 
Previous studies have thoroughly documented changes in cell morphology and stem 
differentiation based on substrate stiffness (Engler et al, 2006; Yeung et al, 2005). The 
brain is a soft organ, with brain tissue having a shear modulus of about 0.49 kPa 
(Rashid et al, 2013), which is much lower than that of a rigid plastic cell culture dish 
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(~ 1 GPa) (Sayed et al, 2015), thus cells may have behaved differently based on the 
substrate used. 
To confirm the validity of the results from initial experiments using hard 
polystyrene cell culture dishes, experiments were repeated using a soft 
substrate that consisted of a coverslip with a polyacrylamide gel layer coated with a type 
I collagen layer. First, to confirm the presence of collagen on the polyacrylamide gel 
layer, the specimens were stained with Coomassie Blue. The results indicated that some 
protein may be present on both the polyacrylamide gel coverslip and the polyacrylamide 
gel + type I collagen coverslip. This may have been due to unsuccessful destaining 
procedure, or actual presence of type I collagen or some other protein on both coverslips. 
Despite Coomassie Blue stain results, cells were seeded on the polyacrylamide gel + type 
I collagen coverslips. After 24 hours, it was evident that the Neuro2A cells seeded 
on the polyacrylamide gel + type I collagen coverslips had adhered. Since type I collagen 
was necessary for cell adherence to the substrate, the results indicate that the type I 
collagen immobilization was successful. Images showed that Neuro2A cells plated on the 
soft substrate exhibited little neurite outgrowth following serum-free culture, especially 
when compared to that of Neuro2A cells in cell culture dishes (Figure 9). However, some 
cells with neurite extension were identified and the results demonstrate that 
Neuro2A neurites retract significantly after 1 hour of exposure to 35 mmHg pressure on 
the soft substrate. This finding supports the view that the hard substrate experiments 
serve as valid models for studying elevated ICP on neuronal cell morphology in vitro.  
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5.3 p160 ROCK Inhibition 
Previous studies have shown that the Rho/ROCK pathway is responsible for neurite 
retraction induced by external stimuli such as LPA (Hirose et al, 1988; Monnier et al, 
2003). However, none have yet examined how hydrostatic pressure specifically induces 
neurite retraction.  When the p160ROCK inhibitor Y-27632 was administered to neuronal 
cell cultures prior to pressure exposure (35 mmHg for 1 hour), there was 
significantly (p<0.05) less neurite retraction when compared to the cultures that were 
exposed to pressure without prior administration of Y-27632, suggesting that Y-27632 
blocked the effects of  Additionally, when LPA was administered to Neuro2A cells in the 
present study neurite retraction occurred as expected. However, when cells were treated 
with Y-27632 prior to LPA, the effect of LPA was blocked. These results indicate that 
hydrostatic pressure is transduced to induce neurite retraction through the same pathway 
that LPA is and that the pathway responsible is the Rho/ROCK pathway.  
5.4 Apoptosis Study 
Numerous studies have demonstrated that neuronal cell death occurs as a result of 
TBI (Pekna et al, 2012; Xiong et al, 2009). Specific causes such as ischemia to brain 
tissue, diffuse axonal injury, and direct trauma to neuronal cells have been 
identified as contributors (Gaetz, 2004; Werner et al, 2007). The present study 
investigated whether elevated hydrostatic pressure contributed to the neuronal cell 
death and a commercially available TUNEL assay kit (Trevigen) was used to quantify 
apoptotic cells in a control group and groups exposed to pressure. Results demonstrate 
that following 24 hours of exposure to 35 mmHg pressure, similar and minimal Neuro2A 
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cell apoptosis occurred for the control and pressure groups. While the values of the 
nuclease-treated group were similar to the other groups, it was due to the large variance 
and, the nuclease-treated absorbance values in two out of three trials were higher (~1.15) 
than those represented in Figure 12. Although these in vitro results suggest that elevated 
hydrostatic pressure alone is likely not responsible for neuronal cell death, it remains 
possible that in the presence of other cell types in the in vivo environment, other 
mechanisms may be involved that would lead to neuronal cell apoptosis due to elevated 
ICP. 
 5.5 Limitations 
As previously discussed, the present study used an in vitro system to model TBI-
associated elevated ICP. While hydrostatic pressure could be closely monitored and 
controlled, the scope of the study was limited in regard to several factors.  
In the present study, pressure experiments relied on the measurement of 
extensions from Neuro2A cell bodies, collectively called “neurites”. Neurites include 
both axons and dendrites, however the two were not distinguished from each other for 
simplicity of data collection and analysis in the study.  
Throughout the study, Neuro2A cells were cultured in an incubator with a 
humidified atmosphere of 95% air and 5% CO2 at 37°C. This models hyperventilation, 
which is not representative of physiological conditions experienced in healthy brain 
tissue. Normally, neurons present in brain conrtex are exposed to low oxygen levels 
(Ndubuizu et al, 2007). Therefore, oxygen concentration would need to be adjusted to 
more accurately model physiological conditions in future studies. 
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In the pressure experiments, Neuro2A cells were first cultured in growth medium, 
then switched to serum-free medium after 24 hour to induce neurite extension. Pressure 
experiments were carried out while cells were in serum-free medium, however cells in 
brain tissue exposed to elevated ICP would have access to additional nutrients in the 
environment. For a more accurate TBI model, cells should be cultured with complete 
nutrients available in brain tissue, as cells may behave differently.  
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CHAPTER SIX 
CONCLUSIONS AND RECCOMENDATIONS 
In the present study, exposure to elevated hydrostatic pressure (35 mHg) for at 
least 30 minutes was proven to induce neurite retraction in Neuro2A cells in vitro. 
However, 24-hour exposure to elevated hydrostatic pressure did not induce neuronal 
apoptosis. Additionally, the study provides evidence that the pressure-induced neurite 
retraction response is mediated by the Rho/ROCK pathway. The presented findings may 
be applied to future TBI pathology studies in order to elucidate potential solutions to 
treating elevated ICP. Future studies include the following:  
• To clarify the effect of hydrostatic pressure on neuronal apoptosis by
performing additional experiments that expose Neuro2A cells to 35 mmHg 
hydrostatic pressure for 24 hours and 48 hours.  
o Rationale: Current results suggest that minimal apoptosis occurs
after 24 hours of exposure to 35 mmHg hydrostatic pressure, however 
the positive control values remained low. Additional trials of the 
experiment should be run. Further, longer exposure to hydrostatic 
pressure may elucidate apoptotic events later on. 
• To identify and examine the components present in the neurite structures
using stains for actin and microtubules before and after pressure exposure in 
Neuro2A cells. 
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o Rationale: Specification of molecular components and their
activity may provide information regarding Rho/ROCK pathway 
mechanisms involved in pressure-induced neurite retraction. 
• To establish in vitro synapse formation by using a stem cell-derived
neuron platform such as induced pluripotent stem cells (Bradford et al, 2015) 
in order to evaluate the effect of hydrostatic pressure on synapses. 
o Rationale: Current results suggest hydrostatic pressure induces
neurite retraction which may indicate loss in synapses. However, there 
is no evidence that synapse destruction does occur.  
• To investigate the effects of hydrostatic pressure on an animal brain tissue
sample. 
o Rationale: Since all physiological structures and cell types are
included in the brain tissue sample, it would provide a highly accurate 
model for TBI-related ICP studies.  
• To combine the application of hydrostatic pressure with another model of
TBI pathology in order to produce a more relevant TBI disease model. 
o Rationale: In order to achieve the most accurate model, all
environmental factors should be included. Other studies without ICP 
elevation considerations may not produce accurate results. Elevated 
ICP may exacerbate pathological conditions or influence cells.    
• To investigate the effects of hydrostatic pressure application on a co-
culture composed of multiple cell types naturally present in brain tissue 
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including primary neurons, astrocytes, oligodendrocytes, and microglia from a 
rat.   
o Rationale: Primary neurons are a better representation of cells in 
the brain than Neuro2A cells, and would therefore serve as better 
predictors for neuronal behavior to elevated hydrostatic pressure 
experienced during brain swelling following TBI. While neurons may 
be the primary functioning cell type in brain tissue, it is important to 
evaluate the response of the surrounding support cells as well. 
Elevated hydrostatic pressure may have an effect on these cell types 
independently, or may induce them to impact neurons in an indirect 
way.   
• To investigate the effects of hydrostatic pressure application on a brain 
tissue- like construct seeded with multiple cell types naturally present in brain 
tissue including primary neurons, astrocytes, oligodendrocytes, and 
microglia.   
o Rationale: Cells may respond in a different manner when exposed 
to hydrostatic pressure while on a compliant soft tissue model as 
compared to soft substrates in plastic dishes.   
• To conduct an animal study in which two mice receive blunt TBIs, 
followed by the administration of Y-27632 in one mouse, and no treatment in 
the other. Following the injury and recovery time, mouse behavior would be 
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evaluated. Extraction and analysis of brain tissue morphology would be 
examined post-humously.   
o Rationale: A mouse model would provide evidence as to whether
the inhibitor has an effect on the mouse behavior or brain tissue 
morphology as compared to the control.  
• To examine cell morphology in brain tissue samples after rat brain is
exposed to elevated hydrostatic pressure, and compare these to brain tissue 
samples of healthy rat brain.   
o Rationale: When investigating cell behavior and response to
stimuli, actual tissue samples provide more accurate evidence than do 
cell culture models.   
• To determine through which specific receptor hydrostatic pressure
stimulates neurite retraction in neuronal cells. 
o Rationale: Another potential target for drug therapy may be the
specific receptor involved in pressure-mediated responses. 
• To develop a live imaging pressure chamber system to record videos or
take time-lapse images of cells in real time. 
o Rationale: This would allow investigators to observe neuronal
morphological change in real-time and better assess cell behavior, as 
well as provide clearer evidence to support the conclusion that 35 
mmHg pressure causes neurite retraction in Neuro-2A cells.  
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